PZRXQ — PZ Wind Down Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Phaserx Says Auction For Nearly All Of Co's Assets Was Held, But Did Not Conclude
Brief: Phaserx Revokes Proposed Distribution Record Date
Brief: PhaseRx Receives Decision From Nasdaq Hearings Panel For Continued Listing Of Shares
Brief: Phaserx Commences Voluntary Chapter 11 Bankruptcy Protection Proceeding
Brief: PhaseRx Receives Positive Opinion for Orphan Drug Designation for PRX-ASL from EMA
Brief: PhaseRx reports Q3 loss per share $0.23
Brief: Phaserx gets delisting notice from NASDAQ
Brief: Phaserx announces corporate restructuring and review of strategic alternatives
Brief: PhaseRx receives Orphan Drug Designation from FDA for PRX-ASL
Brief: Phaserx reports Q2 loss per share $0.30
Brief: PhaseRx files for stock and warrants offering of up to $15 mln
Brief: Phaserx gets positive opinion for orphan drug designation for PRX-OTC from EMA
Brief: PhaseRx reports Q4 loss per share of $0.30
Brief: PhaseRx receives orphan drug designation from FDA for PRX-OTC
Brief: Phaserx announces positive safety results from large animal study with hybrid mRNA delivery technology
Brief: PhaserX Q3 loss per share $0.29
Brief: PhaseRx appoints Peggy Phillips to board of directors
Brief: Phaserx posts Q2 loss per share $1.84
Brief: PhaseRx says advances product pipeline for treatment of rare genetic liver diseases